Quantitative determination of endogenous nitric oxide in the mouse skin in vivo by microdialysis

European Journal of Pharmacology

Volumn 332, Issue 3, 1997, Pages 279-282

  Andoh, Tsugunobu ^a   Kuraishi, Yasushi ^a  

^a Fac Pharmaceutical Sci   (Japan)

Author keywords

Bradykinin; Bradykinin B2 receptor; Inflammatory hyperalgesia; Microdialysis; N(G) hitro L arginine methyl ester; Nitric oxide (NO); Skin

Indexed keywords

BRADYKININ; BRADYKININ ANTAGONIST; N(G) NITROARGININE METHYL ESTER; NITRIC OXIDE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DRUG DETERMINATION; MALE; MICRODIALYSIS; MOUSE; NONHUMAN; PRIORITY JOURNAL; QUANTITATIVE ASSAY; SKIN; TECHNIQUE;

ANIMALS; BENZOATES; BRADYKININ; ENZYME INHIBITORS; IMIDAZOLES; MALE; MICE; MICE, INBRED ICR; MICRODIALYSIS; NG-NITROARGININE METHYL ESTER; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; RECEPTOR, BRADYKININ B2; RECEPTORS, BRADYKININ; SKIN;

EID: 0030865761     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0014-2999(97)01114-X     Document Type: Article

References (19)

1. ·N O through a radical reaction Biochemistry. 32:1993;827-832.
2. Balcioglu A., Maher T.J. Determination of kainic acid-induced release of nitric oxide using a novel hemoglobin trapping technique with microdialysis. J. Neurochem. 61:1993;2311-2313.
3. Barabé J., Marceau F., Theriault B., Drouin J.N., Regoli D. Cardiovascular actions of kinins in the rabbit. Can. J. Physiol. Pharmacol. 57:1979;78-91.
4. Bockmann S., Paegelow I. Bradykinin receptors in signal transduction pathways in peritoneal guinea pigs macrophages. Eur. J. Pharmacol. 291:1995;159-165.
5. Dray A., Perkins M. Bradykinin and inflammatory pain. Trends Neurosci. 16:1993;99-104.
6. Feletou M., Bonnardel E., Canet E. Bradykinin and changes in microvascular permeability in the hamster cheek pouch: Role of nitric oxide. Br. J. Pharmacol. 118:1996;1371-1376.
7. Geppetti P. Sensory neuropeptide release by bradykinin: Mechanisms and pathophysiological implications. Regul. Pept. 47:1993;1-23.
8. Ialenti A., Ianaro A., Moncada S., Rosa M.D. Modulation of acute inflammation by endogenous nitric oxide. Eur. J. Pharmacol. 211:1992;177-182.
9. Ignarro L.J., Buga G.M., Wood K.S., Byrns R.E., Chaudhuri G. Endothelium-derived relaxing factor produced and released from artery and vein is nitric oxide. Proc. Natl. Acad. Sci. USA. 84:1987;9265-9269.
10. Khalil Z., Helme R.D. The quantitative contribution of nitric oxide and sensory nerves to bradykinin-induced inflammation in rat skin microvasculature. Brain Res. 589:1992;102-108.
11. Khasar S.G., Miao F.J., Levine J.D. Inflammation modulates the contribution of receptor-subtypes to bradykinin-induced hyperalgesia in the rat. Neuroscience. 69:1995;685-690.
12. Marletta M.A., Yoon P.S., Iyengar R., Leaf C.D., Wishnok J.S. Macrophage oxidation of L-arginine to nitrite and nitrate: Nitric oxide is an intermediate. Biochemistry. 27:1988;8706-8711.
13. Nakamura A., Fujita M., Shiomi H. Involvement of endogenous nitric oxide in the mechanism of bradykinin-induced peripheral hyperalgesia. Br. J. Pharmacol. 117:1996;407-412.
14. Ohta K., Araki N., Shibata M., Hamada J., Komatsumoto S., Shimazu K., Fukuuchi Y. A novel in vivo assay system for consecutive measurement of brain nitric oxide production combined with the microdialysis technique. Neurosci. Lett. 176:1994;165-168.
15. Palmer R.M.J., Ashton D.S., Moncada S. Vascular endothelial cells synthesize nitric oxide from L-arginine. Nature. 333:1988;664-666.
16. Regoli D., Barabé J. Pharmacology of bradykinin and related kinin. Pharmacol. Rev. 32:1980;1-46.
17. Steranka L.R., Manning D.C., De Haas C.J., Ferkany J.W., Borosky S.A., Connor J.R., Vavrek R.J., Stewart J.M. Bradykinin as a pain mediator: Receptors are localized to sensory neurons, and antagonists have analgesic actions. Proc. Natl. Acad. Sci. USA. 85:1988;3245-3249.
18. Sung C.P., Arleth A.J., Shikano K., Berkowitz B.A. Characterization and function of bradykinin receptors in vascular endothelial cells. J. Pharmacol. Exp. Ther. 247:1988;8-13.
19. Warren J.B., Loi R.K. Captopril increases skin microvascular blood flow secondary to bradykinin, nitric oxide, and prostaglandins. FASEB J. 9:1995;411-418.